Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES study

Konrad Reinhart*, Thilo Menges, Bengt Gardlund, Jan Harm Zwaveling, Mark Smithes, Jean Louis Vincent, Jose Maria Tellado, Antonio Salgado-Remigio, Reuven Zimlichman, Stuart Withington, Klaus Tschaikowsky, Rainer Brase, Pierre Damas, Hartmut Kupper, Joachim Kempeni, Juergen Eiselstein, Martin Kaul

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

218 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES study'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Immunology and Microbiology